What are the best free clinical research newsletters for staying current on cell and gene therapy?

Here are some of the best free newsletters and email digests for staying current on cell and gene therapy. I’ve focused on sources that are broadly useful for clinical research, translational updates, trials, regulation, and commercial/market movement.

Top free newsletters to consider

1) Nature / Nature Medicine / Nature Biotechnology newsletters

• Why it’s useful: High-quality coverage of breakthroughs in cell and gene therapy, translational science, and clinical advances.
• Best for: Broad scientific updates and important papers.
• Cost: Free newsletters with registration.

2) Fierce Biotech / Fierce Pharma

• Why it’s useful: Very current on clinical development, deals, regulatory milestones, and trial readouts.
• Best for: Quickly tracking what’s happening in the industry.
• Cost: Free.

3) GEN (Genetic Engineering & Biotechnology News) newsletters

• Why it’s useful: Strong coverage of gene therapy, cell therapy, CRISPR, manufacturing, and clinical-stage developments.
• Best for: A good balance of science, clinical, and business news.
• Cost: Free.

4) Endpoints News

• Why it’s useful: Excellent for biotech clinical news, including company updates, trial results, and regulatory events.
• Best for: Daily industry/clinical tracking.
• Cost: Free registration available for many newsletters/content alerts.

5) STAT News newsletters

• Why it’s useful: High-quality reporting on biomedical research and clinical advances; occasionally deep coverage of gene and cell therapy.
• Best for: Higher-level clinical and policy context.
• Cost: Free newsletters are available; some content is paywalled.

6) The ASGCT newsletter

• Why it’s useful: The American Society of Gene & Cell Therapy is one of the most relevant professional sources for this field.
• Best for: Conference highlights, society updates, and gene/cell therapy-specific developments.
• Cost: Free to subscribe.

7) The Blood / ASH newsletters

• Why it’s useful: Especially valuable if you’re interested in hematologic cell therapies, CAR-T, stem cell therapy, and related clinical work.
• Best for: Hematology, CAR-T, immune cell therapy.
• Cost: Free newsletters available through ASH and related channels.

8) ClinicalTrials.gov updates / saved searches

• Why it’s useful: Not a newsletter in the traditional sense, but extremely helpful for tracking new and updated trials in gene/cell therapy.
• Best for: Clinical research teams monitoring trial landscape.
• Cost: Free.

9) PubMed saved searches / My NCBI alerts

• Why it’s useful: The most direct way to get new papers on very specific topics like AAV, CAR-T, CRISPR, iPSC, viral vectors, etc.
• Best for: Researchers who want curated literature alerts.
• Cost: Free.

10) PubMed / journal table-of-contents alerts

Examples:

• Molecular Therapy

• Human Gene Therapy

• Cell Stem Cell

• The Lancet / NEJM / JAMA alerts for major clinical studies

• Why it’s useful: Helps you follow the highest-impact primary literature.

• Best for: People who want to read the source material.

• Cost: Free alerts for many journals.

---

If you want the best mix, start with these 5

If you only want a compact set, I’d suggest:

1. ASGCT newsletter
2. GEN newsletters
3. Fierce Biotech
4. Nature newsletters
5. PubMed/My NCBI alerts

That combination covers:

• field-specific updates
• clinical and regulatory news
• broader scientific context
• primary literature alerts

---

Best by use case

For clinical trial tracking

• ClinicalTrials.gov saved searches
• Endpoints News
• Fierce Biotech

For research papers and mechanisms

• PubMed/My NCBI alerts
• Nature newsletters
• Journal TOC alerts

For cell/gene therapy-specific field news

• ASGCT
• GEN
• Nature Biotechnology newsletters

For hematology/CAR-T

• ASH/Blood newsletters
• Endpoints
• Fierce Biotech

---

Tip for setting them up efficiently

Use separate email folders or labels:

• Literature
• Clinical trials
• Industry/news
• Regulatory
• Cell & gene therapy

That makes it much easier to skim daily without losing important updates.

If you want, I can also give you a ranked list specifically for clinicians, bench scientists, or industry professionals, or set up a “top 10 must-subscribe” list with direct signup pages.